- Home
- MLGO vs COCP Comparison
MLGO vs COCP Comparison
Compare MLGO & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- COCP
- Stock Information
- Founded
- MLGO 2018
- COCP 2006
- Country
- MLGO China
- COCP United States
- Employees
- MLGO N/A
- COCP N/A
- Industry
- MLGO EDP Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- COCP Health Care
- Exchange
- MLGO Nasdaq
- COCP Nasdaq
- Market Cap
- MLGO 15.6M
- COCP 15.7M
- IPO Year
- MLGO N/A
- COCP N/A
- Fundamental
- Price
- MLGO $0.74
- COCP $1.80
- Analyst Decision
- MLGO
- COCP Strong Buy
- Analyst Count
- MLGO 0
- COCP 1
- Target Price
- MLGO N/A
- COCP $6.00
- AVG Volume (30 Days)
- MLGO 42.8M
- COCP 21.6K
- Earning Date
- MLGO 04-28-2025
- COCP 08-13-2025
- Dividend Yield
- MLGO N/A
- COCP N/A
- EPS Growth
- MLGO N/A
- COCP N/A
- EPS
- MLGO 0.55
- COCP N/A
- Revenue
- MLGO $74,185,505.00
- COCP N/A
- Revenue This Year
- MLGO N/A
- COCP N/A
- Revenue Next Year
- MLGO N/A
- COCP N/A
- P/E Ratio
- MLGO $1.31
- COCP N/A
- Revenue Growth
- MLGO N/A
- COCP N/A
- 52 Week Low
- MLGO $0.50
- COCP $1.12
- 52 Week High
- MLGO $117.20
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MLGO 39.13
- COCP 69.71
- Support Level
- MLGO $0.58
- COCP $1.46
- Resistance Level
- MLGO $0.88
- COCP $1.60
- Average True Range (ATR)
- MLGO 0.10
- COCP 0.08
- MACD
- MLGO 0.15
- COCP 0.02
- Stochastic Oscillator
- MLGO 64.33
- COCP 92.31
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).